P
PAINCHEK LTD
ASX: PCK (PAINCHEK FPO [PCK])
Last update: yesterday, 6:54AM0.059
0.00 (3.51%)
| Previous Close | 0.057 |
| Open | 0.060 |
| Volume | 7,969,642 |
| Avg. Volume (3M) | 4,492,630 |
| Market Cap | 122,277,784 |
| Price / Sales | 33.63 |
| Price / Book | 39.30 |
| 52 Weeks Range | |
| Earnings Date | 28 Jul 2025 - 1 Aug 2025 |
| Profit Margin | -269.86% |
| Operating Margin (TTM) | -190.43% |
| Diluted EPS (TTM) | -0.010 |
| Quarterly Revenue Growth (YOY) | 27.20% |
| Current Ratio (MRQ) | 1.80 |
| Operating Cash Flow (TTM) | -7.79 M |
| Levered Free Cash Flow (TTM) | -4.72 M |
| Return on Assets (TTM) | -114.82% |
| Return on Equity (TTM) | -457.46% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Health Information Services (AU) | Mixed | Mixed |
| Health Information Services (Global) | Bullish | Mixed | |
| Stock | PAINCHEK FPO [PCK] | - | - |
AIStockmoo Score
0.3
| Analyst Consensus | 0.0 |
| Insider Activity | NA |
| Price Volatility | -5.0 |
| Technical Moving Averages | 3.5 |
| Technical Oscillators | 2.5 |
| Average | 0.25 |
|
Painchek Ltd is engaged in the development and commercialization of mobile medical device applications, that automate intelligent pain assessment of individuals who are unable to communicate pain with carers. It operates in one segment namely sale of pain assessment solutions. |
|
| Sector | Healthcare |
| Industry | Health Information Services |
| Investment Style | Small Growth |
| % Held by Insiders | 34.46% |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |